CardioComm Solutions Inc. (EKG) - Cash Flow Conversion Efficiency
Based on the latest financial reports, CardioComm Solutions Inc. (EKG) has a cash flow conversion efficiency ratio of 0.215x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-121.85K) by net assets (CA$-567.74K). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
CardioComm Solutions Inc. - Cash Flow Conversion Efficiency Trend (2013–2024)
This chart illustrates how CardioComm Solutions Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
CardioComm Solutions Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of CardioComm Solutions Inc. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
FDM Group Holdings PLC
LSE:FDM
|
0.181x |
|
Rajdarshan Industries Limited
NSE:ARENTERP
|
-0.005x |
|
Avidian Gold Corp
V:AVG
|
-0.020x |
|
Cho Thavee Public Company Limited
BK:CHO
|
-0.006x |
|
Scheerders van Kerchove's Verenigde fabrieken nv
BR:SCHD
|
0.091x |
|
22nd Century Group Inc
NASDAQ:XXII
|
0.174x |
|
Lyra Therapeutics Inc
NASDAQ:LYRA
|
1.701x |
|
Centenario Gold Corp.
V:CTG
|
0.065x |
Annual Cash Flow Conversion Efficiency for CardioComm Solutions Inc. (2013–2024)
The table below shows the annual cash flow conversion efficiency of CardioComm Solutions Inc. from 2013 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CA$-276.58K | CA$-110.66K | 0.400x | +273.45% |
| 2023-12-31 | CA$-504.65K | CA$-54.07K | 0.107x | +180.05% |
| 2022-12-31 | CA$-407.32K | CA$54.52K | -0.134x | -146.91% |
| 2021-12-31 | CA$-423.38K | CA$-120.80K | 0.285x | +585.41% |
| 2020-12-31 | CA$-670.32K | CA$39.40K | -0.059x | -185.08% |
| 2019-12-31 | CA$-895.81K | CA$-61.89K | 0.069x | -97.55% |
| 2018-12-31 | CA$-68.41K | CA$-192.53K | 2.814x | +572.08% |
| 2017-12-31 | CA$489.32K | CA$-291.70K | -0.596x | -102.26% |
| 2016-12-31 | CA$-7.74K | CA$-204.16K | 26.374x | +6060.44% |
| 2015-12-31 | CA$-687.89K | CA$-294.50K | 0.428x | -44.88% |
| 2014-12-31 | CA$-595.83K | CA$-462.75K | 0.777x | -72.03% |
| 2013-12-31 | CA$-339.45K | CA$-942.44K | 2.776x | -- |
About CardioComm Solutions Inc.
CardioComm Solutions, Inc. develops advanced software and hardware products, and core laboratory reading services related to electrocardiogram (ECG) and ambulatory arrhythmia monitoring systems for medical and consumer markets worldwide. The company offers consumer health monitoring products, including GEMS mobile ECG, GEMS mobile RPM, HeartCheck CardiBeat " Mobile ECG device, and HeartCheck SMAR… Read more